Skip to main content

Marshall Wace, LLP

SEC CIK
0001318757
Latest filing
Aug 13, 2026

WST holding history

West Pharmaceutical Services Inc in every 13F filed by Marshall Wace, LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

WST overviewAll 13F holders of WSTFull Q2 2026 holdings

Shares (Q2 2026)
83,578
Value
$30.0M
% of portfolio
<0.1%
Quarters held
20
Since Q2 2021
Holdings of WST by Marshall Wace, LLP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202683,578$30.0M<0.1%+82,005+5,213.3%AddedHolders
Q1 20261,573$394.3K<0.1%−34,052−95.6%ReducedHolders
Q4 202535,625$9.80M<0.1%+34,825+4,353.1%AddedHolders
Q3 2025800$209.9K<0.1%−61,726−98.7%ReducedHolders
Q2 202562,526$13.7M<0.1%−103,573−62.4%ReducedHolders
Q1 2025166,099$37.2M<0.1%−61,166−26.9%ReducedHolders
Q4 2024227,265$74.4M0.1%+99,006+77.2%AddedHolders
Q3 2024128,259$38.5M<0.1%+80,280+167.3%AddedHolders
Q2 202447,979$15.8M<0.1%−327,699−87.2%ReducedHolders
Q1 2024375,678$148.7M0.2%+312,531+494.9%AddedHolders
Q4 202363,147$22.2M<0.1%−90,614−58.9%ReducedHolders
Q3 2023153,761$57.7M0.1%+114,994+296.6%AddedHolders
Q2 202338,767$14.8M<0.1%−19,272−33.2%ReducedHolders
Q1 202358,039$20.1M<0.1%+56,983+5,396.1%AddedHolders
Q4 20221,056$248.5K<0.1%−112,121−99.1%ReducedHolders
Q3 2022113,177$27.8M0.1%+87,634+343.1%AddedHolders
Q2 202225,543$7.72M<0.1%+25,543NewHolders
Q1 20220$00.0%−199−100.0%Sold outHolders
Q4 2021199$93.0K<0.1%−248,900−99.9%ReducedHolders
Q3 2021249,099$105.8M0.5%+93,783+60.4%AddedHolders
Q2 2021155,316$55.8M0.3%+155,316NewHolders